Loading...
Loading...
Cranberry, D-mannose or vaginal estrogen? What the trials show for repeat UTIs after menopause, and what a supplement can and cannot claim.
You finish a course of antibiotics, and six weeks later the burning is back. After menopause that pattern is common enough that urology guidelines address it directly, and pharmacy shelves are full of cranberry pills and D-mannose powders. Here is what the trials found, in the order the evidence supports, as read on October 10, 2026.
One thing first: if you have a fever, chills, pain in your back or side, vomiting, or blood you can see in your urine, this is not a supplement question. Contact a clinician today. Everything below is about preventing the next infection, not treating the one you have now.
Vaginal estradiol, prescribed online.
Compare all providers · Take the 60-second quiz
Partner link: we may earn a commission, at no extra cost to you.
Falling estrogen changes both the tissue and the bacteria in and around the vagina. In a 1993 trial of postmenopausal women with repeat UTIs, the lactobacilli that normally keep the vagina acidic were missing before treatment, vaginal pH was raised, and two-thirds had gut bacteria of the kind that includes E. coli growing in the vagina. Clinicians call these changes, with the dryness and urgency that come with them, genitourinary syndrome of menopause (GSM). Bladder prolapse, urine left in the bladder after you go, and incontinence are also linked to repeat infections in this age group.
Raz and Stamm, 1993: lactobacilli "were absent in all vaginal cultures before treatment," average vaginal pH was 5.5, and 67 percent had Enterobacteriaceae growing in the vagina.
Cochrane review, 2008: "The main factors associated with RUTI in postmenopausal women are vesical prolapse, cystocoele, post-voidal residue and urinary incontinence, all associated with a decrease in oestrogen."
GSM on its own can feel like an infection, which is why a urine culture matters. See our guides to telling a UTI from menopause symptoms and to recurrent UTIs and menopause.
Vaginal estrogen. According to a 2026 peer-reviewed review of the guidelines, the American Urological Association's guideline on recurrent UTIs says clinicians should recommend vaginal estrogen to peri- and postmenopausal women with recurrent UTIs when there is no contraindication, and European urology guidance recommends it too. It is a low dose of estrogen placed in the vagina as a cream, tablet or ring, and in randomized trials it reduced repeat infections. The FDA-approved products are labeled for menopause-related vaginal changes, not for UTI prevention, so this use rests on the trials and guidelines.
It is a long-term routine rather than a rescue treatment; in a 1993 cream trial and a 1999 ring trial, women used it for about eight months. Our guide to using vaginal estrogen covers schedules, and our vaginal estrogen page compares creams, tablets and rings.
Estrogen pills have not been shown to. In the Cochrane review, oral estrogen did no better than placebo at preventing UTIs in postmenopausal women (four trials, 2,798 women), and a 2021 meta-analysis of three oral estrogen trials found the same. Those reviews covered pills and vaginal products, and we found no trial showing that patches or gels prevent UTIs. If you take systemic HRT for hot flashes and still get repeat infections, it has not been shown to do that job; vaginal estrogen is a separate, local treatment.
Cochrane review, 2008: "Oral oestrogens did not reduce UTI compared to placebo (4 studies, 2798 women: RR 1.08, 95% CI 0.88 to 1.33)."
Anyone with a history of breast cancer or another hormone-sensitive cancer, unexplained vaginal bleeding, a past blood clot, stroke or heart attack, or liver disease should raise it before starting, because these appear among the contraindications on vaginal estrogen labels. Very little estrogen reaches the bloodstream at low doses, but it is a prescription medicine whose labeling, which differs by product, your clinician weighs. For breast cancer survivors, the labels and specialist guidance do not say the same thing, so that decision is made with the oncology team.
If you need a clinician who prescribes vaginal estrogen, our directory lists menopause providers by state.
Probably, for women who get repeat UTIs, though the effect is modest. The 2023 Cochrane review of 50 trials found, with moderate-certainty evidence, that cranberry products probably reduce culture-confirmed UTIs in women with recurrent UTIs by about a quarter on average. That result is for women with recurrent UTIs in general, not specifically after menopause. The review found little or no benefit in older people living in care homes, and it could not show that higher doses of the active compounds (proanthocyanidins, or PACs) worked better than lower ones.
Cochrane review, 2023: "cranberry products probably reduced the risk of symptomatic, culture-verified UTIs in women with recurrent UTIs (8 studies, 1555 participants: RR 0.74, 95% CI 0.55 to 0.99)." That range runs from about a 45 percent reduction to almost none. On dose, "No difference in the risk for UTIs could be demonstrated between low, moderate and high doses of PACs."
If you take warfarin, ask your clinician or pharmacist first: the NIH's National Center for Complementary and Integrative Health calls the evidence on an interaction conflicting, and says cranberry "isn't recommended as a treatment for existing UTIs in any population."
Only a qualified claim, and the qualifier is part of it. In 2020 the FDA said it would not object to cranberry supplement labels saying they may help reduce the risk of recurrent UTIs in healthy women, provided the label also says the scientific evidence is limited. The FDA's wording covers supplements with at least 500 mg of cranberry fruit powder a day. A label or website that shows the first sentence without the second has dropped the FDA's qualifier.
The FDA's claim for cranberry supplements, verbatim: "Consuming 500 mg each day of cranberry dietary supplement may help reduce the risk of recurrent urinary tract infection (UTI) in healthy women. FDA has concluded that there is limited scientific evidence supporting this claim."
A large 2024 trial found that it did not. In the MERIT trial, 598 women with recurrent UTIs in UK primary care (average age 58, and 63 percent past menopause) took 2 g of D-mannose or a placebo powder every day for six months. About half of each group still had a suspected UTI that needed medical attention, 51.0 percent with D-mannose and 55.7 percent with placebo, a difference that could have been chance. The researchers concluded that D-mannose should not be recommended for prevention in this group.
MERIT, JAMA Internal Medicine, 2024: results were similar before and after menopause, though the trial was "not powered to detect differences in subgroups."
A 2022 Cochrane review had found "little to no evidence to support or refute the use of D-mannose," and a smaller 2023 trial adding it to vaginal estrogen was stopped early, too small to show a difference either way. MERIT's main limitation: it counted clinically suspected UTIs, not culture-confirmed ones.
UTI Biome Shield is a dietary supplement sold by Good Kitty Co. Its website lists each daily capsule as containing 38 mg of cranberry PACs (measured by the DMAC method), 500 mg of D-mannose, 400 IU of vitamin D3 and 2 mg of zinc picolinate, plus other cranberry compounds. The directions are one capsule a day and two more before sex. Like other supplements, it was not approved by the FDA before sale, and Good Kitty's own FAQ calls it "prevention, not treatment."
Vaginal estradiol, prescribed online.
Compare all providers · Take the 60-second quiz
Partner link: we may earn a commission, at no extra cost to you.
Of its ingredients, cranberry has good trial support, but the product itself has not been tested. We found no published clinical trial of UTI Biome Shield in PubMed or ClinicalTrials.gov (searched October 10, 2026); the studies Good Kitty cites are of individual ingredients. The only product-specific data on its research page is exploratory before-and-after microbiome testing, which Good Kitty says "should not be interpreted as evidence that UTI Biome Shield prevents UTIs." The D-mannose in each capsule is a quarter of the 2 g daily dose that showed no benefit in MERIT.
Who might still consider it: someone with culture-confirmed recurrent UTIs who wants a non-prescription add-on, or who cannot use vaginal estrogen, and who accepts that the evidence is for cranberry in general, not this product. It does not replace a urine culture, treatment of a current infection, or a conversation about vaginal estrogen. If you decide to try it, it is sold on Good Kitty's website. Dietary supplements are not evaluated by the FDA to diagnose, treat, cure or prevent disease.
Low-dose antibiotics are a standard way to prevent recurrent UTIs, taken as a small daily dose or as a single dose after sex, and whether they suit you is your clinician's call, weighing benefit against side effects and resistance. Methenamine hippurate (Hiprex) is a non-antibiotic prescription option: in a 2022 UK trial of 240 women, it met the trial's test for being no worse than daily low-dose antibiotics over 12 months.
Get same-day care for fever, chills, pain in your back or side, nausea or vomiting, which can mean the infection has reached the kidneys, and for new confusion in an older person. Blood you can see in your urine always needs checking. If you could be pregnant, tell your clinician before taking anything. Call back if your symptoms are not improving within a couple of days of starting antibiotics, or if they return soon after you finish. None of these is a time to try a supplement first.
MedlinePlus: "Contact your provider right away if you have signs of a possible kidney infection, such as: Back or side pain, Chills, Fever, Vomiting." And: "Never ignore blood you see in your urine."
Start with a urine culture and a conversation about vaginal estrogen, the option with guideline backing. Cranberry probably helps a little, as an add-on or if estrogen is not for you. D-mannose did not work in the 2024 trial, and a combination supplement like UTI Biome Shield has not been tested as a product.
Vaginal estradiol, prescribed online.
Gala lists vaginal estradiol as "local relief for dryness, painful intercourse, and recurrent UTIs." A 5-minute symptom assessment, a US-licensed provider reviews your case, typically within 24 hours, free 1-2 day shipping, and $69 a month with no price rise when your dose changes.
Not sure which platform fits you? Take the 60-second match quiz or compare the best online HRT of 2026.
How getting started works
Share your health history
A short online questionnaire, about 5 minutes. No appointment and no waiting room.
A licensed clinician reviews
A licensed provider checks your history and, if HRT is right for you, writes the prescription.
Delivered to your door
Your treatment ships to you, usually within days, with ongoing check-ins and dose adjustments.
Some links above are partnerships. If you start care through them, we may earn a commission at no extra cost to you. Partners we can earn from may be shown first in some lists, but commission never changes the facts we report about any provider.
The information on FindMyHRT is for educational and informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment. Never disregard professional medical advice or delay seeking it because of something you have read on this website.
Everything you need before your first appointment, in one guide you can print:
Free. We'll email you the kit, then three short notes over the next ten days or so. Unsubscribe anytime. We never share your email.